The Role of Interleukin-17 in Lung Cancer
Joint Authors
Xu, Juanjuan
Wu, Feng
Huang, Qi
Han, Jieli
Duan, Limin
Fan, Jinshuo
Lv, Zhilei
Guo, Mengfei
Hu, Guorong
Chen, Lian
Zhang, Shuai
Tao, Xiaonan
Ma, Wanli
Jin, Yang
Source
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-10-30
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Tumour-associated inflammation is a hallmark of malignant carcinomas, and lung cancer is a typical inflammation-associated carcinoma.
Interleukin-17 (IL-17) is an important inflammatory cytokine that plays an important role in chronic inflammatory and autoimmune diseases and in inflammation-associated tumours.
Numerous studies have shown that IL-17 directly or indirectly promotes tumour angiogenesis and cell proliferation and that it inhibits apoptosis via the activation of inflammatory signalling pathways.
Therefore, IL-17 contributes to the metastasis and progression of lung cancer.
Research advances with respect to the role of IL-17 in lung cancer will be presented as a review in this paper.
American Psychological Association (APA)
Wu, Feng& Xu, Juanjuan& Huang, Qi& Han, Jieli& Duan, Limin& Fan, Jinshuo…[et al.]. 2016. The Role of Interleukin-17 in Lung Cancer. Mediators of Inflammation،Vol. 2016, no. 2016, pp.1-6.
https://search.emarefa.net/detail/BIM-1111261
Modern Language Association (MLA)
Wu, Feng…[et al.]. The Role of Interleukin-17 in Lung Cancer. Mediators of Inflammation No. 2016 (2016), pp.1-6.
https://search.emarefa.net/detail/BIM-1111261
American Medical Association (AMA)
Wu, Feng& Xu, Juanjuan& Huang, Qi& Han, Jieli& Duan, Limin& Fan, Jinshuo…[et al.]. The Role of Interleukin-17 in Lung Cancer. Mediators of Inflammation. 2016. Vol. 2016, no. 2016, pp.1-6.
https://search.emarefa.net/detail/BIM-1111261
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1111261
